Congenital disordersRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID Posted on November 27, 2023November 27, 2023 by yun 27 Nov Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID yun Dydrogesterone exposure during early pregnancy associated with the reporting of birth defects, says Global PV Study Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases
